Crux Biomedical

edit

Crux Biomedical, Inc., was formed in August 2004 by physicians Tom Fogarty and Frank Arko based upon their observations of the clinical limitations of current vena cava filters.

Milestones

edit

• Received $8M in Series B funding. (1/09)
  Posted 4/19/09 at 9:12am

Videos

Screenshots

edit

Above: Home page
Uploaded: 5/9/09

Sources

1. Crux pumps in $8M to prevent embolisms (venturebeat.com) [edit]